ELIMINATION OF CERTAIN LABELING REQUIREMENTS.

SEC. 126. ELIMINATION OF CERTAIN LABELING REQUIREMENTS. (a) Prescription Drugs.—Section 503(b)(4) (21 U.S.C. 353(b)(4)) is amended to read as follows: “(4)(A) A drug that is subject to paragraph (1) shall be deemed to be misbranded if at any time prior to dispensing the label of the drug fails to bear, at a minimum, the symbol ‘Rx only’. “(B) A drug to which paragraph (1) does not apply shall be deemed to be misbranded if at any time prior to dispensing the label of the drug bears the symbol described in subparagraph (A).”. (b) Misbranded Drug.—Section 502(d) (21 U.S.C. 352(d)) is repealed. (c) Conforming Amendments.— (1) Section 503(b)(1) (21 U.S.C. 353(b)(1)) is amended— (A) by striking subparagraph (A); and 111 STAT. 2328 (B) by redesignating subparagraphs (B) and (C) as subparagraphs (A) and (B), respectively. (2) Section 503(b)(3) (21 U.S.C. 353(b)(3)) is amended by striking “section 502(d) and”. (3) Section 102(9)(A) of the Controlled Substances Act (21 U.S.C. 802(9)(A)) is amended— (A) in clause (i), by striking “(i)”; and (B) by striking “(h)” and all that follows.